Associations - EGFR G719A

BIOMARKER:

EGFR G719A

Entrez ID:

Related biomarkers:

‹

›

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

EGFR G719A EGFR G719A	Non Small Cell Lung Cancer NSCLC	dacomitinib Sensitive: C2 – Inclusion Criteria J Clin Oncol - 2 weeks dacomitinib Sensitive : C2 J Clin Oncol - 2wk
EGFR G719A EGFR G719A	Non Small Cell Lung Cancer NSCLC	gefitinib Sensitive: B - Late Trials gefitinib Sensitive : B
EGFR G719A EGFR G719A	Non Small Cell Lung Cancer NSCLC	erlotinib Sensitive: C2 – Inclusion Criteria erlotinib Sensitive : C2
EGFR G719A EGFR G719A	Non Small Cell Lung Cancer NSCLC	osimertinib Sensitive: C3 – Early Trials osimertinib Sensitive : C3